PLoS ONE (Jan 2018)

Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.

  • Andrzej Lange,
  • Emilia Jaskula,
  • Janusz Lange,
  • Grzegorz Dworacki,
  • Dorota Nowak,
  • Aleksandra Simiczyjew,
  • Monika Mordak-Domagala,
  • Mariola Sedzimirska

DOI
https://doi.org/10.1371/journal.pone.0209108
Journal volume & issue
Vol. 13, no. 12
p. e0209108

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0190525.].